| Cell subset |
Anti-HAV ≥20mIU/mL (n=23) |
Anti-HAV <20mIU/mL (n=6) |
Mann Whitney test (p) |
CD4+ T cells(cells/mm3)
(range) |
634.1
(188.1, 1295.0) |
200.4
(8.7, 736.7) |
0.004 |
Naïve: CD45RA+CCR7+ (%)
(range) |
29.9
(9.7, 61.9) |
20
(6.9, 30.3) |
0.026 |
Central Memory: CD45RA-CCR7+ (%)
(range) |
9.63
(3.81, 18.1) |
7.13
(1.01, 17.9) |
0.414 |
Effector Memory: CD45RA-CCR7- (%)
(range) |
31.6
(14.4, 60.3) |
50.2
(28.1, 68.1) |
0.014 |
Terminally Differentiated: CD45RA+CCR7- (%)
(range) |
21.7
(12.2, 55.1) |
18.6
(6.8, 63.9) |
0.511 |
Activated CD3+CD4+CD38+ HLADR+(%)
(range) |
12.6
(7.9, 26.0) |
24.8
(10.6 , 49.0) |
0.054 |
CD8+ T cells (cells/mm3)
(range) |
929.4
(529.9, 1852.8) |
375.6
(104.0, 1633.5) |
0.102 |
Naïve: CD45RA+CCR7+ (%)
(range) |
17.2
(8.6, 52.4) |
5.6
(2.2, 39.1) |
0.080 |
Central Memory: CD45RA-CCR7+ (%)
(range) |
1.2
(0,2.8) |
1.8
(1,4.2) |
0.694 |
EffectorMemory: CD45RA-CCR7- (%)
(range) |
44.6
(1.7, 66) |
62.6
(33.7, 78.0) |
0.080 |
Terminally Differentiated: CD45RA+CCR7- (%)
(range) |
28.5
(17.1, 89.6) |
27.4
(13.8, 35.2) |
0.384 |
Activated CD3+CD8+CD38+ HLADR+ (%)
(range) |
22.0
(7.5, 59.3) |
51.4
(30.8, 68.5) |
0.002 |
B cells: CD19+ cells (cells/mm3)
(range) |
334.54
(76.53, 632.7) |
103.21
(6,78, 121,4) |
<0.001 |
Immature Transitional(CD19+CD10+)(%)
(range) |
33.6
(9.2, 82.9) |
31.4
(10.1, 69.3) |
0.655 |
Naive (CD21+CD27-) (%)
(range) |
68.2
(37.2, 89.5) |
52.1
(9.7, 69.6) |
0.009 |
Resting Memory (CD21+CD27+) (%)
(range) |
13.7
(4.6, 36.2) |
9.8
(4.0, 17.4) |
0.158 |
ActivatedMemory (CD21-CD27+)(%)
(range) |
6.8
(0.7, 21.7) |
18.9
(6.9, 32.8) |
0.004 |
Exhausted Memory (CD21-CD27-) (%)
(range) |
8.1
(0.4, 31.8) |
22.6
(7.0, 60.7) |
0.031 |
NK cells (cells/mm3)
(range) |
209.3
(22.8, 429.3) |
67.3
(35.6, 93.9) |
0.002 |
Activated CD3-CD16+/CD56+CD38+ (%)
(range) |
78.5
(49.1, 96.1) |
81.8
(44.7, 99.6) |
0.733 |
*Mann Whitney test |
